Boston Scientific vs Stryker (BSX vs SYK)
Boston Scientific (BSX) vs Stryker (SYK) in plain English: P/E, growth, margins, debt and dividend side by side, key differences and which fits each investor profile.
Boston Scientific (BSX) and Stryker (SYK) compete in healthcare and pharma. Here are Boston Scientific and Stryker side by side with their real figures as of November 4, 2026: what sets them apart, which fits each kind of investor and the most common questions, without telling you whether to buy Boston Scientific or Stryker.
Boston Scientific vs Stryker: the figures
| Figure | Boston Scientific | Stryker |
|---|---|---|
| Share price | $45.82 (November 4, 2026) | $339.65 (November 4, 2026) |
| Market cap | $66.4 billion | $129.3 billion |
| P/E (TTM) | 19.3x | 36.2x |
| Forward P/E | 14.6x | 20.8x |
| Revenue growth (quarter) | +1.4% | +7.6% |
| Net margin (TTM) | 16.6% | 13.8% |
| Net debt / EBITDA | 2.0x | 1.6x |
| Dividend yield | 0.00% | 1.13% |
| Beta | 0.58 | 0.77 |
Boston Scientific and Stryker figures from Yahoo Finance, the same source the Fintols analysis uses, retrieved on November 4, 2026; N/A means that Boston Scientific or Stryker figure is not available, and we never estimate it.
3 key differences between Boston Scientific and Stryker
- Valuation: Stryker trades at 36.2x its annual earnings and Boston Scientific at 19.3x; the market pays more for each dollar of Stryker profit, usually because it expects more growth.
- Dividend: Stryker pays a dividend yielding 1.13% and Boston Scientific pays none.
- Growth: Stryker grew sales +7.6% year on year in its latest quarter, against +1.4% for Boston Scientific.
Boston Scientific or Stryker: which fits your profile
- If you want growth: Stryker is growing faster today, so it fits better with investors who put business growth first, usually accepting a higher P/E and a bumpier ride.
- If you want income (dividends): Stryker pays the higher dividend relative to its price.
- If you prefer caution: Stryker has less debt relative to its profit, which usually gives more room in a bad year.
- If price is what matters most to you: Boston Scientific trades on the lower P/E; check first whether that is an opportunity or a sign of a business that grows less.
Neither Boston Scientific nor Stryker wins on everything, and owning both is also an option: spreading money across several companies or an index fund reduces what rides on each one.
How Boston Scientific and Stryker make money
Boston Scientific (BSX)
Boston Scientific makes devices for minimally invasive procedures. Its Cardiovascular segment, the larger one, includes the Farapulse ablation system, the Watchman heart implant and stents, while MedSurg covers endoscopy, urology and neuromodulation products. Customers are hospitals and clinics across the United States, Europe and Asia. Full Boston Scientific analysis.
Stryker (SYK)
Stryker sells medical equipment to hospitals through two segments. MedSurg and Neurotechnology covers surgical instruments, emergency equipment, hospital beds and neurovascular devices, while Orthopaedics includes hip and knee implants and the Mako surgical robot. The United States is its largest market, followed by Europe and Asia. Full Stryker analysis.
Frequently asked questions: Boston Scientific vs Stryker
Is Boston Scientific or Stryker the better stock?
Choosing between Boston Scientific and Stryker depends on what you are looking for. Stryker is growing faster right now, and Boston Scientific trades on the lower P/E. Fintols does not tell you whether to buy Boston Scientific or Stryker: it shows you the differences so you can decide.
Which pays a higher dividend, Boston Scientific or Stryker?
As of November 4, 2026, Stryker yields 1.13% and Boston Scientific pays none. Also check how much of their profit Boston Scientific and Stryker pay out: if it is more than they earn, it cannot last.
Which is more expensive, Boston Scientific or Stryker?
On P/E, Stryker (36.2x) is more expensive than Boston Scientific (19.3x) as of November 4, 2026. A higher P/E can be justified if earnings grow faster, so compare it with each company's growth in the table.
Can I own both Boston Scientific and Stryker?
Yes. Many people spread their money across several companies, such as Boston Scientific and Stryker, or use index funds so they do not depend on just one. If you are starting out, decide how much you want to invest and for how long before buying Boston Scientific or Stryker.
More comparisons with Boston Scientific or Stryker
- Boston Scientific vs Vertex
- Boston Scientific vs Novo Nordisk
- Stryker vs Vertex
- Novo Nordisk vs Stryker
More companies like Boston Scientific and Stryker: healthcare and pharma stocks. Educational content about Boston Scientific and Stryker, not investment advice.